Created as a holding company in 2019, SEVER Life Sciences brings together three diverse but complementary companies, each with their own specialist focus. As a result, SEVER Life Sciences oversees an unrivalled and uniquely successful series of products, services and technologies.
Very few companies the size of SEVER Life Sciences can boast of being able to develop, register, manufacture, license, distribute and market their own pharmaceutical products. Equally, virtually no company of SEVER Life Sciences’ size has the same geographical reach.
Our base is Europe but we also have a strong presence in Canada, Japan, and the USA. Our international focus means that where others might see obstacles, we see opportunities.